Fulcrum Therapeutics Inc. (FULC)
NASDAQ: FULC
· Real-Time Price · USD
6.45
-0.35 (-5.15%)
At close: Jun 17, 2025, 3:59 PM
6.42
-0.47%
After-hours: Jun 17, 2025, 04:55 PM EDT
Fulcrum Therapeutics Revenue
Fulcrum Therapeutics reported an annual revenue of $80M, reflecting a 2752.05% growth. For the quarter ending March 31, 2025, Fulcrum Therapeutics generated $0 in revenue.
Revenue (ttm)
$80M
Revenue Growth
2752.05%
Price / Sales Ratio
3.64
Revenue / Employee
$1.78M
Employees
45
Market Cap
348.17M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|